Is Nangibotide legal in the US?
Not yet; it is still in trials.
BSome human evidenceIn clinical trialsas of 2026-10-26
Not approved by the FDA for any use. Nangibotide is an investigational drug for septic shock; a phase 2b trial has been published, and its authors say a further trial is needed to confirm any benefit. 1
Read the full Nangibotide page
More on Nangibotide
Citations
- François 2023, Lancet Respir Med: nangibotide in patients with septic shock (ASTONISH), randomized phase 2b trial doi.org
Reference information only, not medical advice. Drawn from the Nangibotide article, fact-checked against the cited sources. No dosing anywhere on this site.